To avoid the limitations of traditional tumor markers and achieve early diagnosis of HCC, the concept of new tumor markers has been proposed: GPC3 is a cell surface proteoglycan, similar to AFP, which is usually undetectable in healthy adult livers and can be observed only in fetal livers. Here, AFP is linked to hepatocellular carcinoma.